獣医診断市場 : 2029年までの世界予測

Report Overview

The veterinary diagnostics market is valued at an estimated USD 3.3 billion in 2023 and is projected to reach USD 5.0 billion by 2029, at a CAGR of 7.1% during the forecast period. The veterinary diagnostics market is influenced mainly by the rise in animals such as dogs and cats, increase in the insurance for companion animals, global animal healthcare expenditure, increased adoption and awareness about animal health in emerging economies, rise in parasitic infections in animals, etc.

“The instruments segment is projected to have the highest growth in this market.”
Veterinary diagnostic instruments mainly include diagnostic test analyzers and portable analyzers. These analyzers measure the physiologically significant substances present in body fluids (blood, serum, plasma, and urine) and feces of animals. Diagnostic test analyzers include clinical chemistry analyzers, glucose monitors, blood gas-electrolyte analyzers, urine analyzers, hematology analyzers, lateral flow strip readers, and immunodiagnostic analyzers. Major market players offer analyzers separately, along with reagent clips, cartridges, panels, and kits used in disease diagnosis. Increasing technological advancement and the incorporation of AI tools in instruments are factors influencing its growth.

“Clinical Biochemistry segment accounted for the largest share after immunodiagnostics in the technology segment.”
Clinical biochemistry accounted for the second largest share in the technology market. It is an important technology used for screening infectious and metabolic disorders in small animals. Diseases and disorders evaluated using this technology can range from studying kidney function, diabetes, electrolyte & hormone evaluation, and liver function to systemic inflammation caused by infectious agents such as bacteria, viruses, and parasites. Clinical biochemistry analyzers are more widely adopted in veterinary diagnostics laboratories, which leads to a higher share in the veterinary diagnostics market. Large number of cases of glucose testing. Clinical testing, and electrolyte testing have influenced the market.

“Asia Pacific market to witness the highest growth during the forecast period.”
During the forecast period, APAC is anticipated to grow at the fastest rate. The major factors promoting the growth of the veterinary diagnostics market in this region are awareness about animal health, growing per capita income, government initiative for increasing adoption of pets, rise in production of livestock products, especially by China and India, and increase in diseases among animals.

A breakdown of the primary participants (supply-side) for the veterinary diagnostics market referred to for this report is provided below:
a
• By Company Type: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
• By Designation: C-level Executives: 23%, Directors: 30%, and Others: 47%
• By Region: North America: 33%, Europe: 20%, Asia Pacific: 28%, Latin America: 13%; Middle East and Africa: 59%;

The prominent players operating in the veterinary diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific Inc. (US), bioMérieux SA (France), Heska Corporation (US), NEOGEN Corporation (US), Bio-Rad Laboratories Inc. (US), Virbac (France), FUJIFILM Holdings Corporation (Japan), Shenzhen Mindray Animal Medical Technology Co. Ltd. (China), INDICAL BIOSCIENCE GmbH (Germany), BioNote, Inc. (South Korea), Biogal Galed Labs (Israel), Agrolabo S.p.A. (Italy), Innovative Diagnostics (France), Randox Laboratories Ltd. (Ireland), BioChek (Netherlands), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), Gold Standard Diagnostics (Germany), Precision Biosensor Inc. (South Korea), Antech Diagnsotics Inc. (US), and EUROIMMUN Medizinische Labordiagnostika AG (Germany).

Research Coverage:
The market study covers the veterinary diagnostics market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by product, application, technology, distribution channel, animal type, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall veterinary diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:
 Analysis of key drivers (Rise in companion animals, growing demand for products derived from animals, increased zoonotic disease cases, increase in pet insurance, increase in disease control and disease prevention measures), restraints (Rising pet cost care and high cost of diagnostic tests), opportunities (untapped emerging market) and challenges (lack fo animal health awareness, and shortage of veterinary practitioners) influencing the growth of the veterinary diagnostics market
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary diagnostics market. The report analyzes this market by type of product, application, technology, animal type, distribution channel, end-user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global veterinary diagnostics market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product, application, technology, animal type, distribution channel, end-user, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global veterinary diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global veterinary diagnostics market.

Table of Contents

1            INTRODUCTION            63

1.1         STUDY OBJECTIVES      63

1.2         MARKET DEFINITION   63

1.2.1      INCLUSIONS AND EXCLUSIONS 63

1.3         MARKET SCOPE             64

1.3.1      MARKETS COVERED     64

1.3.2      YEARS CONSIDERED     65

1.3.3      CURRENCY CONSIDERED          66

1.4         STAKEHOLDERS            66

1.5         SUMMARY OF CHANGES            66

1.5.1      RECESSION IMPACT      67

2            RESEARCH METHODOLOGY     68

2.1         RESEARCH DATA           68

FIGURE 1           RESEARCH DESIGN       68

2.1.1      SECONDARY DATA       69

2.1.1.1   Key data from secondary sources     70

2.1.2      PRIMARY DATA 70

FIGURE 2           PRIMARY SOURCES       70

2.1.2.1   Key data from primary sources         71

2.1.2.2   Key industry insights          72

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION  72

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND  DEMAND-SIDE PARTICIPANTS 73

2.2         MARKET SIZE ESTIMATION       73

FIGURE 5           SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS          74

FIGURE 6           REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.    74

FIGURE 7           SUPPLY-SIDE ANALYSIS OF TOP COMPANIES: VETERINARY DIAGNOSTICS MARKET (2022)  75

FIGURE 8           CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY  DIAGNOSTICS MARKET (2023–2029)       76

FIGURE 9           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   77

FIGURE 10         TOP-DOWN APPROACH             78

2.3         MARKET BREAKDOWN AND DATA TRIANGULATION    79

FIGURE 11         MARKET DATA TRIANGULATION METHODOLOGY       79

2.4         MARKET SHARE ANALYSIS         80

2.5         ASSUMPTIONS 80

2.6         LIMITATIONS   80

2.7         RISK ASSESSMENT         81

TABLE 1             RISK ASSESSMENT: VETERINARY DIAGNOSTICS MARKET              81

2.8         RECESSION IMPACT ANALYSIS 81

3            EXECUTIVE SUMMARY 82

FIGURE 12         VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2023 VS. 2029 (USD MILLION)     82

FIGURE 13         VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2023 VS. 2029 (USD MILLION)     83

FIGURE 14         VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2023 VS. 2029 (USD MILLION)             83

FIGURE 15         VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2023 VS. 2029 (USD MILLION)             84

FIGURE 16         VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2023 VS. 2029 (USD MILLION)          85

FIGURE 17         VETERINARY DIAGNOSTICS MARKET, BY END USER,  2023 VS. 2029 (USD MILLION)     85

FIGURE 18         GEOGRAPHICAL SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET            86

4            PREMIUM INSIGHTS      87

4.1         VETERINARY DIAGNOSTICS MARKET OVERVIEW           87

FIGURE 19         GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH        87

4.2         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET,  BY END USER AND COUNTRY (2022)  88

FIGURE 20         VETERINARY REFERENCE LABORATORIES ACCOUNTED FOR  LARGEST SHARE OF APAC MARKET IN 2022       88

4.3         VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           89

FIGURE 21         CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD              89

4.4         VETERINARY DIAGNOSTICS MARKET:  DEVELOPED MARKETS VS. EMERGING ECONOMIES            90

FIGURE 22         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD            90

5            MARKET OVERVIEW     91

5.1         MARKET DYNAMICS     91

FIGURE 23         VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    91

5.1.1      DRIVERS            92

5.1.1.1   Growth in companion animal population       92

TABLE 2             NUMBER OF US HOUSEHOLDS THAT OWN A PET, BY ANIMAL TYPE (MILLIONS)          92

TABLE 3             PET POPULATION, BY ANIMAL, 2014–2022 (MILLION)    93

5.1.1.2   Rising demand for animal-derived food products         93

FIGURE 24         MAJOR PRODUCERS OF COW MILK WORLDWIDE IN 2022, BY COUNTRY (MILLION METRIC TONS)     94

TABLE 4             PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES        94

TABLE 5             ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS,  2000 VS. 2030 (THOUSAND METRIC TONS) 95

TABLE 6             ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS,  2000 VS. 2030 (THOUSAND METRIC TONS) 95

5.1.1.3   Increasing incidence of transboundary and zoonotic diseases     96

TABLE 7             ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)       96

5.1.1.4   Rising demand for pet insurance and growing animal health expenditure 97

TABLE 8             US: AVERAGE ANNUAL PREMIUMS PAID (2020–2022)      98

FIGURE 25         US VS CANADA: GROSS WRITTEN PREMIUMS FOR DOGS,  2020–2022 (IN USD MILLION)     98

FIGURE 26         US VS CANADA: GROSS WRITTEN PREMIUMS FOR CATS,  2020–2022 (IN USD MILLION) 99

FIGURE 27         US: PET INDUSTRY EXPENDITURE, 2010–2022    99

TABLE 9             US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020–2022 (USD BILLION) 100

TABLE 10           NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2022 (USD MILLION)     100

5.1.1.5   Growing number of veterinary practitioners and rising income levels in developed economies           101

TABLE 11           NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2020      101

5.1.1.6   Increasing disease control and prevention measures     101

5.1.2      RESTRAINTS     102

5.1.2.1   Rising pet care costs           102

FIGURE 28         US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2022              102

5.1.2.2   High cost of veterinary diagnostic tests          103

5.1.3      OPPORTUNITIES           103

5.1.3.1   Untapped emerging markets            103

5.1.4      CHALLENGES   104

5.1.4.1   Lack of animal healthcare awareness in emerging countries        104

5.1.4.2   Shortage of veterinary practitioners in emerging economies       104

TABLE 12           NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS 2014 VS 2018      105

5.2         INDUSTRY TRENDS       105

5.2.1      ADOPTION OF MULTIPLE TEST PANELS            105

TABLE 13           MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS              105

5.2.2      OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES              106

5.2.3      GROWING CONSOLIDATION IN VETERINARY DIAGNOSTICS INDUSTRY         106

TABLE 14           MAJOR ACQUISITIONS IN ANIMAL HEALTH DIAGNOSTICS INDUSTRY         106

5.2.4      GROWING SCALE OF VETERINARY BUSINESSES 106

5.3         DISEASE TRENDS           107

5.3.1      LIVESTOCK       107

5.3.1.1   Avian Influenza    107

5.3.1.2   African Swine Fever           107

5.3.1.3   Bovine Babesiosis 107

5.3.1.4   Peste des Petits Ruminants 107

5.3.1.5   West Nile Virus   107

5.3.2      COMPANION ANIMALS 107

5.3.2.1   Zoonotic diseases 107

TABLE 15           COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS           108

5.3.2.2   Obesity & diabetes             109

5.4         TECHNOLOGY ANALYSIS           109

5.4.1      KEY TECHNOLOGIES    109

5.4.1.1   Portable instruments for POC diagnostic services        109

TABLE 16           POC PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS AND MANUFACTURERS             109

5.4.2      ADJACENT TECHNOLOGIES      110

5.4.2.1   Rapid and sensitive veterinary diagnostic kits 110

5.4.3      COMPLEMENTARY TECHNOLOGIES     110

5.5         PRICING ANALYSIS        111

TABLE 17           REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2022 (USD)        111

5.5.1      AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION 112

TABLE 18           AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP 3 APPLICATIONS (USD)   112

5.5.2      AVERAGE SELLING PRICE TRENDS, BY REGION 112

5.6         VALUE CHAIN ANALYSIS            112

FIGURE 29         VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS              113

5.7         ECOSYSTEM/MARKET MAP       113

FIGURE 30         VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP      114

5.8         PORTER’S FIVE FORCES ANALYSIS         114

TABLE 19           VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS          114

5.8.1      THREAT OF NEW ENTRANTS    115

5.8.2      THREAT OF SUBSTITUTES         115

5.8.3      BARGAINING POWER OF SUPPLIERS     116

5.8.4      BARGAINING POWER OF BUYERS           116

5.8.5      INTENSITY OF COMPETITIVE RIVALRY 116

5.9         SUPPLY CHAIN ANALYSIS          116

FIGURE 31         VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS          118

5.10       TARIFF AND REGULATORY LANDSCAPE            118

5.10.1    REGULATORY ANALYSIS            118

5.10.1.1 US         118

5.10.1.2 Europe  119

5.10.1.3 Rest of the world  119

5.10.2    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          120

5.10.2.1 North America     120

TABLE 20           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS       120

5.10.2.2 Europe  122

TABLE 21           EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS      122

5.10.2.3 Rest of the world  123

TABLE 22           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS       123

5.11       PATENT ANALYSIS        123

5.11.1    PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS              123

FIGURE 32         PATENT PUBLICATION TRENDS (JANUARY 2013-OCTOBER 2023)    124

5.11.2    JURISDICTION AND TOP APPLICANT ANALYSIS             124

FIGURE 33         TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR  VETERINARY DIAGNOSTICS PATENTS (JANUARY 2013–OCTOBER 2023)             125

FIGURE 34         TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2013–OCTOBER 2023)           125

5.12       KEY CONFERENCES AND EVENTS (2023–2025)   126

TABLE 23           VETERINARY DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS    126

5.13       KEY STAKEHOLDERS AND BUYING CRITERIA    127

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         127

FIGURE 35         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS      127

TABLE 24           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS      127

5.13.2    BUYING CRITERIA         128

FIGURE 36         KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS              128

TABLE 25           KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS              128

5.14       TRADE ANALYSIS          128

TABLE 26           TOP EXPORTERS OF VETERINARY DIAGNOSTIC CONSUMABLES (REAGENTS; COMPOSITE DIAGNOSTIC OR LABORATORY), 2022      129

5.15       CASE STUDIES  130

TABLE 27           INCREASE IN PATIENT VISITS AND DIAGNOSTIC PROCEDURES              130

TABLE 28           UNMET CUSTOMER NEEDS IN LIVESTOCK DIAGNOSTICS MARKET            130

TABLE 29           OPPORTUNITY ASSESSMENT IN HIGH-END AUTOMATED IMMUNOASSAY ANALYZERS IN COMPANION ANIMAL IMMUNODIAGNOSTICS              131

TABLE 30           IDENTIFICATION OF INTESTINAL PARASITE     131

5.16       ADJACENT MARKETS    131

FIGURE 37         VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS              131

5.17       END-USER PERSPECTIVE & UNMET NEEDS        132

5.18       AI INTEGRATION IN VETERINARY DIAGNOSTICS           132

6            VETERINARY DIAGNOSTICS MARKET, BY PRODUCT      133

6.1         INTRODUCTION            134

TABLE 31           VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 134

6.2         CONSUMABLES 134

6.2.1      CONSUMABLES TO HOLD LARGEST SHARE OF PRODUCTS MARKET              134

TABLE 32           KEY VETERINARY DIAGNOSTIC CONSUMABLES, BY COMPANY (2022)   135

TABLE 33           VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 136

6.3         INSTRUMENTS 137

6.3.1      INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET              137

TABLE 34           KEY VETERINARY DIAGNOSTIC INSTRUMENTS, BY COMPANY (2022)   137

TABLE 35           VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 138

7            VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY           139

7.1         INTRODUCTION            140

TABLE 36           VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)     140

7.2         IMMUNODIAGNOSTICS             140

TABLE 37           KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS, BY COMPANY         141

TABLE 38           VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          142

TABLE 39           VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY,  2021–2029 (USD MILLION)          143

7.2.1      LATERAL FLOW ASSAYS             143

TABLE 40           LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 144

TABLE 41           LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 144

7.2.1.1   Lateral flow rapid tests       145

7.2.1.1.1 Lateral flow rapid tests to dominate market    145

TABLE 42           LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     145

7.2.1.2   Lateral flow strip readers   146

7.2.1.2.1 Rising need for readers to determine analyte quantity to drive adoption   146

TABLE 43           LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     146

7.2.2      ELISA   147

7.2.2.1   Cost-effectiveness and ease of use to drive demand      147

TABLE 44           ELISA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)              147

7.2.3      ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS       148

7.2.3.1   Increasing incidence of allergies in companion animals to drive market growth              148

TABLE 45           ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY,  2021–2029 (USD MILLION)         148

7.2.4      IMMUNOASSAY ANALYZERS      149

7.2.4.1   Growing use of immunoassay analyzers for livestock to propel market      149

TABLE 46           IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 149

7.2.5      RADIOIMMUNOASSAYS 150

7.2.5.1   Growing importance, high sensitivity & specificity to drive market           150

TABLE 47           RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 150

7.2.6      OTHER IMMUNODIAGNOSTIC PRODUCTS        151

TABLE 48           OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 151

7.3         CLINICAL BIOCHEMISTRY         152

TABLE 49           KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS, BY COMPANY         152

TABLE 50           VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)          153

TABLE 51           VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    154

7.3.1      CLINICAL CHEMISTRY ANALYSIS           154

TABLE 52           CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     155

TABLE 53           CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     155

7.3.1.1   Clinical chemistry reagent clips & cartridges  156

7.3.1.1.1 Rising number of screening tests performed to drive market      156

TABLE 54           CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY,  2021–2029 (USD MILLION)      156

7.3.1.2   Clinical chemistry analyzers             157

7.3.1.2.1 Increasing installations of clinical chemistry analyzers to propel growth   157

TABLE 55           CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          157

7.3.2      GLUCOSE MONITORING            158

TABLE 56           GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 158

TABLE 57           GLUCOSE MONITORING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 159

7.3.2.1   Blood glucose strips           159

7.3.2.1.1 Growing demand for blood glucose strips in home care settings to drive market              159

TABLE 58           BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 160

7.3.2.2   Glucose monitors 160

7.3.2.2.1 Growing incidence of diabetes in pet animals to drive  adoption of glucose monitors 160

TABLE 59           GLUCOSE MONITORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          161

7.3.2.3   Urine glucose strips           162

7.3.2.3.1 Growing risk of DKA in animals to drive market          162

TABLE 60           URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 162

7.3.3      BLOOD GAS & ELECTROLYTE ANALYSIS            163

TABLE 61           BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)   163

TABLE 62           BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 164

7.3.3.1   Blood gas & electrolyte reagent clips & cartridges        165

7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to boost market growth   165

TABLE 63           BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET,  BY COUNTRY, 2021–2029 (USD MILLION)      165

7.3.3.2   Blood gas & electrolyte analyzers     166

7.3.3.2.1 Growing adoption of analyzers to determine oxygen and carbon dioxide levels in blood to drive market         166

TABLE 64           BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 166

7.4         MOLECULAR DIAGNOSTICS      167

TABLE 65           VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)   167

TABLE 66           VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    168

7.4.1      PCR TESTS        169

7.4.1.1   Increased laboratory usage of PCR in proteomics and genomics to support growth              169

TABLE 67           PCR TESTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)              169

7.4.2      MICROARRAYS 170

7.4.2.1   Growing applications of biochips in identifying infectious diseases to propel market   170

TABLE 68           MICROARRAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          171

7.4.3      NUCLEIC ACID SEQUENCING    172

7.4.3.1   Increased application of nucleic acid sequencing in diagnosis to drive market              172

TABLE 69           NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     172

7.4.4      OTHER MOLECULAR DIAGNOSTIC PRODUCTS 173

TABLE 70           OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)    173

7.5         URINALYSIS      174

TABLE 71           KEY VETERINARY URINALYSIS PRODUCTS, BY COMPANY              174

TABLE 72           VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 174

TABLE 73           VETERINARY URINALYSIS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 175

7.5.1      URINALYSIS CLIPS & CARTRIDGES/PANELS       176

7.5.1.1   Growing use of clips and cartridges in urine analyzers to detect electrolytes to drive market   176

TABLE 74           URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 176

7.5.2      URINE ANALYZERS        177

7.5.2.1   Development of easy-to-use urine analyzers for POC testing to drive market              177

TABLE 75           URINE ANALYZERS MARKET, BY COUNTRY, 2021–2029 USD MILLION)          177

7.5.3      URINE TEST STRIPS       178

7.5.3.1   Rising occurrence of kidney diseases in cats and dogs to support market  178

TABLE 76           URINE TEST STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          178

7.6         HEMATOLOGY 179

TABLE 77           KEY VETERINARY HEMATOLOGY PRODUCTS, BY COMPANY              179

TABLE 78           VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     179

TABLE 79           VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     180

7.6.1      HEMATOLOGY CARTRIDGES    181

7.6.1.1   Extensive use of hematology cartridges along with hematology analyzers for complete blood analysis to fuel growth           181

TABLE 80           HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     181

7.6.2      HEMATOLOGY ANALYZERS      182

7.6.2.1   High usage of hematology analyzers by veterinary hospitals & clinics to support growth   182

TABLE 81           HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 182

7.7         OTHER TECHNOLOGIES            183

TABLE 82           OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY,  2021–2029 (USD MILLION)         183

8            VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE             184

8.1         INTRODUCTION            185

TABLE 83           VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)     185

8.2         COMPANION ANIMALS 185

TABLE 84           VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2021–2029 (USD MILLION) 186

TABLE 85           VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY,  2021–2029 (USD MILLION)           186

TABLE 86           VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY,  2021–2029 (USD MILLION)     187

8.2.1      DOGS   187

8.2.1.1   High insurance coverage for dogs to drive market        187

TABLE 87           CANINE POPULATION, BY COUNTRY, 2014–2022 (MILLION)              188

TABLE 88          VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY,  2021–2029 (USD MILLION)          189

8.2.2      CATS    190

8.2.2.1   Growing pet cat population to support growth             190

TABLE 89           FELINE POPULATION, BY COUNTRY, 2012–2020 (MILLION)              190

TABLE 90           VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2021–2029 (USD MILLION)          191

8.2.3      HORSES             192

8.2.3.1   Growing equine health awareness to drive market        192

FIGURE 38         US: NUMBER OF PRIVATE EQUINE CLINICAL PRACTICES, 2009–2022      192

TABLE 91           VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY,  2021–2029 (USD MILLION) 193

8.2.4      OTHER COMPANION ANIMALS 194

TABLE 92           VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2021–2029 (USD MILLION)           194

8.3         LIVESTOCK       195

TABLE 93           VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION)          195

TABLE 94           VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY,  2021–2029 (USD MILLION)       196

TABLE 95           VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY,  2021–2029 (USD MILLION) 196

8.3.1      CATTLE             197

8.3.1.1   Growing consumption of meat to support market growth           197

FIGURE 39         MEAT PRODUCTION, BY TYPE, 2021–2022 (MILLION TONS)              197

FIGURE 40         MILK PRODUCTION, BY REGION, 2021–2022 (MILLION TONS)              198

TABLE 96           VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY,  2021–2029 (USD MILLION) 198

8.3.2      PIGS     199

8.3.2.1   Growing incidence of infectious diseases to drive market           199

FIGURE 41         ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, EMERGING ECONOMIES VS. DEVELOPED COUNTRIES, 2020–2030           199

TABLE 97           VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2021–2029 (USD MILLION)          200

8.3.3      POULTRY          200

8.3.3.1   Increasing demand for poultry meat to contribute to market growth         200

TABLE 98           VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY,  2021–2029 (USD MILLION) 201

8.3.4      OTHER LIVESTOCK       201

TABLE 99           VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY,  2021–2029 (USD MILLION)         202

9            VETERINARY DIAGNOSTICS MARKET, BY APPLICATION             203

9.1         INTRODUCTION            204

TABLE 100         VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)     204

9.2         INFECTIOUS DISEASES 204

TABLE 101         VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION) 204

TABLE 102         VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY COUNTRY, 2021–2029 (USD MILLION)     205

9.2.1      BACTERIAL INFECTIONS           206

9.2.1.1   Bacterial infections to hold largest share of infectious disease diagnostics 206

TABLE 103         VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY,  2021–2029 (USD MILLION)             207

9.2.2      VIRAL INFECTIONS       207

9.2.2.1   High mutation rate to ensure continued demand for diagnostics 207

TABLE 104         VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY,  2021–2029 (USD MILLION)         208

9.2.3      PARASITIC INFECTIONS             209

9.2.3.1   High prevalence of parasitic infections to propel demand           209

TABLE 105         VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)  210

9.2.4      OTHER INFECTIONS     211

TABLE 106         VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY,  2021–2029 (USD MILLION)             211

9.3         ENDOCRINOLOGY        212

9.3.1      GROWING RISK OF DIABETES TO SUPPORT DEMAND   212

TABLE 107         VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY,  BY COUNTRY, 2021–2029 (USD MILLION)            212

9.4         CARDIOLOGY  213

9.4.1      RISING INCIDENCE OF CARDIAC DISEASES IN DOGS TO DRIVE MARKET            213

TABLE 108         VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY,  BY COUNTRY, 2021–2029 (USD MILLION)    213

9.5         ONCOLOGY      214

9.5.1      HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET        214

TABLE 109         VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY,  BY COUNTRY, 2021–2029 (USD MILLION)    214

9.6         OTHER APPLICATIONS 215

TABLE 110         VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,  BY COUNTRY, 2021–2029 (USD MILLION)        215

10          VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL              216

10.1       INTRODUCTION            217

TABLE 111         VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 217

10.2       DIRECT SALES  217

10.2.1    DIRECT SALES TO HOLD LARGEST MARKET SHARE      217

TABLE 112         VETERINARY DIAGNOSTICS MARKET FOR DIRECT SALES, BY COUNTRY, 2021–2029 (USD MILLION)    219

10.3       WHOLESALERS & DISTRIBUTORS           219

10.3.1    GROWING VOLUME OF INTERNATIONAL SALES TO SUPPORT SEGMENT GROWTH     219

TABLE 113         VETERINARY DIAGNOSTICS MARKET FOR WHOLESALERS & DISTRIBUTORS,  BY COUNTRY, 2021–2029 (USD MILLION)        220

10.4       ONLINE SALES PLATFORMS      221

10.4.1    ONLINE SALES TO SEE HIGHEST GROWTH        221

TABLE 114         VETERINARY DIAGNOSTICS MARKET FOR ONLINE SALES PLATFORMS,  BY COUNTRY, 2021–2029 (USD MILLION)             222

11          VETERINARY DIAGNOSTICS MARKET, BY END USER      223

11.1       INTRODUCTION            224

TABLE 115         VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 224

11.2       VETERINARY REFERENCE LABORATORIES         224

11.2.1    LARGE VOLUME OF SAMPLES RECEIVED BY VETERINARY REFERENCE LABORATORIES TO DRIVE MARKET GROWTH  224

TABLE 116         VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES,  BY COUNTRY, 2021–2029 (USD MILLION)              225

11.3       VETERINARY HOSPITALS & CLINICS      226

11.3.1    GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET            226

FIGURE 42         US: VETERINARIAN CLINICAL PRACTICES, BY TYPE, 2022              226

TABLE 117         VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS,  BY COUNTRY, 2021–2029 (USD MILLION)          227

11.4       POC/IN-HOUSE TESTING          227

11.4.1    EASE OF USE, COST-EFFECTIVENESS, AND SWIFT RESULTS OFFERED BY POINT-OF-CARE TESTS TO DRIVE DEMAND 227

TABLE 118         VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING,  BY COUNTRY, 2021–2029 (USD MILLION)     228

11.5       VETERINARY RESEARCH INSTITUTES & UNIVERSITIES  228

11.5.1    INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES TO SUPPORT GROWTH   228

TABLE 119         VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2021–2029 (USD MILLION)          229

12          VETERINARY DIAGNOSTICS MARKET, BY REGION          230

12.1       INTRODUCTION            231

TABLE 120         VETERINARY DIAGNOSTICS MARKET, BY REGION, 2021–2029 (USD MILLION) 231

12.2       NORTH AMERICA          231

FIGURE 43         NORTH AMERICA: PROJECTED GROWTH IN NUMBER OF VETERINARIANS            232

12.2.1    NORTH AMERICA: RECESSION IMPACT 232

FIGURE 44         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT        233

TABLE 121         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 234

TABLE 122         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 234

TABLE 123         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       234

TABLE 124         NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      235

TABLE 125         NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      235

TABLE 126         NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION) 236

TABLE 127         NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         236

TABLE 128         NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 237

TABLE 129         NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)      237

TABLE 130         NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      237

TABLE 131         NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 238

TABLE 132         NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 238

TABLE 133         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)        238

TABLE 134         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   239

TABLE 135         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION)          239

TABLE 136         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        240

TABLE 137         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION)    240

TABLE 138         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 241

TABLE 139         NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION) 241

12.2.2    US         241

12.2.2.1 US to dominate North American market during forecast period 241

FIGURE 45         US: POPULATION OF DOGS, 2012–2022 (MILLION)          242

FIGURE 46         US: EXPENDITURE ON VET VISITS, 2013–2021    242

TABLE 140         HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020 VS 2021 242

FIGURE 47         US: VETERINARIAN INCOME LEVELS, 2017–2022 243

FIGURE 48         US: NUMBER OF VETERINARIANS, 2016–2021      243

TABLE 141         US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)        244

TABLE 142         US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2020  244

TABLE 143         US: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          245

TABLE 144         US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)          245

TABLE 145         US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 246

TABLE 146         US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 246

TABLE 147         US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          247

TABLE 148         US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          247

TABLE 149         US: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)     247

TABLE 150         US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)   248

TABLE 151         US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 248

TABLE 152         US: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          248

TABLE 153         US: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)     249

TABLE 154         US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          249

TABLE 155         US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION) 249

TABLE 156         US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION)          250

TABLE 157         US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)          250

TABLE 158         US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION) 251

TABLE 159         US: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 251

TABLE 160         US: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)          252

12.2.3    CANADA            252

12.2.3.1 Growing pet adoption in Canada to drive market growth           252

FIGURE 49         CANADA: COMPANION ANIMAL POPULATION, 2020–2022 (MILLION)        253

TABLE 161         CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          253

TABLE 162         CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       254

TABLE 163         CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 254

TABLE 164         CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 255

TABLE 165         CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          255

TABLE 166         CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 255

TABLE 167         CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          256

TABLE 168         CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)            256

TABLE 169         CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         257

TABLE 170        CANADA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          257

TABLE 171         CANADA: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          257

TABLE 172         CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          258

TABLE 173         CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   258

TABLE 174         CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION)          258

TABLE 175         CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        259

TABLE 176         CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION)    259

TABLE 177         CANADA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 259

TABLE 178         CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)          260

12.3       EUROPE             260

TABLE 179         EUROPE: COMPANION POPULATION, 2022 (MILLION)  261

12.3.1    EUROPE: RECESSION IMPACT   262

TABLE 180         EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)          262

TABLE 181         EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          262

TABLE 182         EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       263

TABLE 183         EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 263

TABLE 184         EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 264

TABLE 185         EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          264

TABLE 186         EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 264

TABLE 187         EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          265

TABLE 188         EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)            265

TABLE 189         EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         265

TABLE 190         EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          266

TABLE 191         EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          266

TABLE 192         EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          266

TABLE 193         EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   267

TABLE 194         EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)          267

TABLE 195         EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        268

TABLE 196         EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)       268

TABLE 197         EUROPE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 268

TABLE 198         EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)          269

12.3.2    GERMANY         269

12.3.2.1 Rising awareness of zoonotic diseases to drive market growth    269

TABLE 199         GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 270

TABLE 200         GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       270

TABLE 201         GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 271

TABLE 202         GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 271

TABLE 203         GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)    272

TABLE 204         GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 272

TABLE 205         GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          272

TABLE 206         GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)            273

TABLE 207        GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         273

TABLE 208         GERMANY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 273

TABLE 209         GERMANY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          274

TABLE 210         GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          274

TABLE 211         GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)      274

TABLE 212         GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)          275

TABLE 213         GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        275

TABLE 214         GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE,  2021–2029 (USD MILLION)    275

TABLE 215         GERMANY: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 276

TABLE 216         GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)          276

12.3.3    UK         276

12.3.3.1 Increasing pet ownership to drive market       276

TABLE 217         UK: HOUSEHOLDS WITH PETS (2022)    277

TABLE 218         UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     278

TABLE 219         UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)          278

TABLE 220         UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 279

TABLE 221         UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 279

TABLE 222        UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)          280

TABLE 223         UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          280

TABLE 224         UK: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)     281

TABLE 225         UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 281

TABLE 226         UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 281

TABLE 227         UK: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     282

TABLE 228         UK: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     282

TABLE 229         UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          282

TABLE 230         UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION) 283

TABLE 231         UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)       283

TABLE 232         UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)          284

TABLE 233         UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE,  2021–2029 (USD MILLION) 284

TABLE 234         UK: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 284

TABLE 235         UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)     285

12.3.4    FRANCE             285

12.3.4.1 Willingness of pet owners to spend on pet health to drive market             285

TABLE 236         FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          286

TABLE 237         FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       286

TABLE 238         FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 287

TABLE 239         FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 287

TABLE 240         FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          288

TABLE 241         FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 288

TABLE 242         FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          289

TABLE 243         FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 289

TABLE 244         FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         290

TABLE 245         FRANCE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          290

TABLE 246         FRANCE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          290

TABLE 247         FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          291

TABLE 248         FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   291

TABLE 249         FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)          292

TABLE 250         FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        292

TABLE 251         FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE,  2021–2029 (USD MILLION)    293

TABLE 252         FRANCE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 293

TABLE 253         FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)          294

12.3.5    ITALY   294

12.3.5.1 Rising awareness about pet healthcare to propel market growth 294

TABLE 254         ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          295

TABLE 255         ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)          295

TABLE 256         ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 296

TABLE 257         ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 296

TABLE 258         ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          297

TABLE 259         ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 297

TABLE 260         ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          298

TABLE 261         ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 298

TABLE 262         ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 299

TABLE 263         ITALY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          299

TABLE 264         ITALY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     299

TABLE 265        ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          300

TABLE 266         ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION) 300

TABLE 267         ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)       301

TABLE 268        ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)          301

TABLE 269         ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE,  2021–2029 (USD MILLION) 302

TABLE 270         ITALY: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 302

TABLE 271         ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)          303

12.3.6    SPAIN   303

12.3.6.1 Growing demand for pig and poultry products to aid adoption of veterinary diagnostic products            303

TABLE 272         SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          304

TABLE 273         SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       304

TABLE 274         SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 305

TABLE 275         SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 305

TABLE 276         SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          306

TABLE 277         SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 306

TABLE 278         SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          307

TABLE 279         SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)   307

TABLE 280         SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 308

TABLE 281         SPAIN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          308

TABLE 282         SPAIN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     308

TABLE 283        SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          309

TABLE 284         SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2021–2029 (USD MILLION) 309

TABLE 285         SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)       310

TABLE 286        SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)          310

TABLE 287         SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE,  2021–2029 (USD MILLION) 311

TABLE 288         SPAIN: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 311

TABLE 289         SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)          312

12.3.7    REST OF EUROPE           312

TABLE 290         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 313

TABLE 291         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       313

TABLE 292         REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      314

TABLE 293         REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      314

TABLE 294         REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION) 315

TABLE 295         REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         315

TABLE 296         REST OF EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 315

TABLE 297         REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)      316

TABLE 298         REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      316

TABLE 299         REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)   316

TABLE 300         REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 317

TABLE 301         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)        317

TABLE 302         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   317

TABLE 303         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)          318

TABLE 304         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        318

TABLE 305         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION)    319

TABLE 306         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)    319

TABLE 307         REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION) 320

12.4       ASIA PACIFIC    320

12.4.1    ASIA PACIFIC: RECESSION IMPACT        320

FIGURE 50         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT        321

TABLE 308         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 322

TABLE 309         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 322

TABLE 310         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       323

TABLE 311         ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         323

TABLE 312         ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         324

TABLE 313         ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION) 324

TABLE 314         ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 325

TABLE 315        ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          325

TABLE 316         ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)      326

TABLE 317         ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      326

TABLE 318         ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 327

TABLE 319         ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 327

TABLE 320         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)        327

TABLE 321         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)      328

TABLE 322         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION)          328

TABLE 323         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        329

TABLE 324         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)       329

TABLE 325         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 330

TABLE 326         ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)          330

12.4.2    CHINA  330

12.4.2.1 Large pool of food-producing animals in China to drive market 330

TABLE 327         CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          331

TABLE 328         CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       332

TABLE 329         CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 332

TABLE 330         CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 333

TABLE 331         CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          333

TABLE 332         CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 334

TABLE 333         CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          334

TABLE 334         CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)   334

TABLE 335         CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 335

TABLE 336         CHINA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          335

TABLE 337         CHINA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          335

TABLE 338         CHINA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          336

TABLE 339         CHINA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2021–2029 (USD MILLION)   336

TABLE 340         CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)       336

TABLE 341         CHINA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        337

TABLE 342         CHINA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE,  2021–2029 (USD MILLION)    337

TABLE 343         CHINA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 338

TABLE 344         CHINA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)          338

12.4.3    JAPAN  338

12.4.3.1 Rising awareness about zoonotic diseases and increased pet expenditure to support adoption 338

FIGURE 51         JAPAN: FOOD, SNACK, AND MEDICAL EXPENDITURE FOR CATS AND DOGS (USD) 339

TABLE 345         NUMBER OF DOMESTICATED DOGS AND CATS IN JAPAN, 2012–2020 (THOUSAND)             339

TABLE 346         PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN, 2000 VS. 2030 (THOUSAND METRIC TONS) 340

TABLE 347         JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          340

TABLE 348         JAPAN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       341

TABLE 349         JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 341

TABLE 350         JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 342

TABLE 351         JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          342

TABLE 352         JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 343

TABLE 353         JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          343

TABLE 354         JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)   344

TABLE 355         JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 344

TABLE 356         JAPAN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          344

TABLE 357         JAPAN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          345

TABLE 358        JAPAN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          345

TABLE 359         JAPAN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE,  2021–2029 (USD MILLION)   345

TABLE 360         JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)       346

TABLE 361         JAPAN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        346

TABLE 362         JAPAN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE,  2021–2029 (USD MILLION) 347

TABLE 363         JAPAN: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 347

TABLE 364         JAPAN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)          348

12.4.4    INDIA   348

12.4.4.1 Growing demand for livestock products to support market growth           348

TABLE 365         INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS,  2000 VS. 2030 (THOUSAND METRIC TONS)              349

TABLE 366         INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          349

TABLE 367         INDIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       350

TABLE 368         INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 350

TABLE 369         INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 351

TABLE 370         INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          351

TABLE 371         INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 351

TABLE 372         INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          352

TABLE 373         INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)   352

TABLE 374         INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 352

TABLE 375         INDIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          353

TABLE 376         INDIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)     353

TABLE 377        INDIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          353

TABLE 378         INDIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION) 354

TABLE 379         INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)       354

TABLE 380        INDIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)          355

TABLE 381         INDIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE,  2021–2029 (USD MILLION) 355

TABLE 382         INDIA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 355

TABLE 383         INDIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)          356

12.4.5    AUSTRALIA       356

12.4.5.1 Increase in pet ownership will support market growth  356

TABLE 384         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 357

TABLE 385         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       357

TABLE 386         AUSTRALIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         358

TABLE 387         AUSTRALIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         358

TABLE 388         AUSTRALIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)    359

TABLE 389         AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 359

TABLE 390         AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          360

TABLE 391         AUSTRALIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)            360

TABLE 392         AUSTRALIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      361

TABLE 393         AUSTRALIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 361

TABLE 394         AUSTRALIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          361

TABLE 395         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          362

TABLE 396         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   362

TABLE 397         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)          362

TABLE 398         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        363

TABLE 399         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)       363

TABLE 400         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 364

TABLE 401         AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)          364

12.4.6    SOUTH KOREA 365

12.4.6.1 Growing companion animal population to drive market             365

TABLE 402         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 365

TABLE 403         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       365

TABLE 404        SOUTH KOREA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         366

TABLE 405        SOUTH KOREA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         366

TABLE 406         SOUTH KOREA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION) 367

TABLE 407         SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 367

TABLE 408         SOUTH KOREA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 367

TABLE 409         SOUTH KOREA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)      368

TABLE 410         SOUTH KOREA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      368

TABLE 411         SOUTH KOREA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 368

TABLE 412         SOUTH KOREA: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 369

TABLE 413         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)        369

TABLE 414         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   369

TABLE 415         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION)          370

TABLE 416         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        370

TABLE 417         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)       371

TABLE 418         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 371

TABLE 419         SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)          372

12.4.7    REST OF ASIA PACIFIC  372

TABLE 420         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         373

TABLE 421         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION) 373

TABLE 422         REST OF ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      374

TABLE 423         REST OF ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      374

TABLE 424         REST OF ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION) 375

TABLE 425         REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      375

TABLE 426         REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 375

TABLE 427         REST OF ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)    376

TABLE 428         REST OF ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)       376

TABLE 429         REST OF ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         376

TABLE 430         REST OF ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 377

TABLE 431         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)   377

TABLE 432         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)            377

TABLE 433         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION) 378

TABLE 434         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)   378

TABLE 435         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION)          379

TABLE 436         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)            379

TABLE 437         REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)         380

12.5       LATIN AMERICA             380

TABLE 438         LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010–2022 (MILLION)    381

12.5.1    LATIN AMERICA: RECESSION IMPACT   381

TABLE 439         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,  2021–2029 (USD MILLION) 381

TABLE 440         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 382

TABLE 441         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       382

TABLE 442         LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      383

TABLE 443         LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      383

TABLE 444         LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION) 384

TABLE 445         LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         384

TABLE 446         LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 384

TABLE 447         LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)      385

TABLE 448         LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      385

TABLE 449         LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 385

TABLE 450         LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 386

TABLE 451         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)        386

TABLE 452         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   386

TABLE 453         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION)          387

TABLE 454         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        387

TABLE 455         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION)    388

TABLE 456         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 388

TABLE 457         LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION) 389

12.5.2    BRAZIL 389

12.5.2.1 Well-established and rapidly growing livestock industry in Brazil to promote growth   389

TABLE 458         BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          390

TABLE 459         BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)       390

TABLE 460         BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 391

TABLE 461         BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 391

TABLE 462         BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          392

TABLE 463         BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 392

TABLE 464         BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          393

TABLE 465         BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)   393

TABLE 466         BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         394

TABLE 467         BRAZIL: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          394

TABLE 468         BRAZIL: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          394

TABLE 469         BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          395

TABLE 470         BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   395

TABLE 471        BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION)    395

TABLE 472         BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        396

TABLE 473         BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION)    396

TABLE 474         BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 397

TABLE 475         BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)          397

12.5.3    MEXICO             398

12.5.3.1 Mexico to retain second-largest share in Latin America till 2029 398

TABLE 476         MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          398

TABLE 477         MEXICO: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029(USD MILLION)        398

TABLE 478         MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 399

TABLE 479         MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,  2021–2029 (USD MILLION)          399

TABLE 480         MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 400

TABLE 481         MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION)          400

TABLE 482         MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 401

TABLE 483         MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          401

TABLE 484         MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,  BY PRODUCT, 2021–2029 (USD MILLION)            402

TABLE 485         MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         402

TABLE 486         MEXICO: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          403

TABLE 487         MEXICO: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)          403

TABLE 488         MEXICO: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)          403

TABLE 489         MEXICO: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,  BY TYPE, 2021–2029 (USD MILLION)   404

TABLE 490         MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,  2021–2029 (USD MILLION)          404

TABLE 491         MEXICO: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)        405

TABLE 492         MEXICO: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,  BY TYPE, 2021–2029 (USD MILLION)    405

TABLE 493         MEXICO: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL,  2021–2029 (USD MILLION) 406

TABLE 494         MEXICO: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)          406

12.5.4    REST OF LATIN AMERICA          406

TABLE 495         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      407

TABLE 496         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION)            407

TABLE 497         REST OF LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)              408

TABLE 498         REST OF LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      408

TABLE 499         REST OF LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION) 409

TABLE 500         REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      409

TABLE 501         REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         410

TABLE 502         REST OF LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)    410

TABLE 503         REST OF LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          411

TABLE 504         REST OF LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      411

TABLE 505         REST OF LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         411

TABLE 506         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)             412

TABLE 507         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)              412

TABLE 508         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 412

TABLE 509         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)             413

TABLE 510         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)              413

TABLE 511         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)         414

TABLE 512         REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)      414

12.6       MIDDLE EAST & AFRICA             415

12.6.1    LOW PORK PRODUCTION AND CONSUMPTION IN MIDDLE EASTERN COUNTRIES DUE TO RELIGIOUS CUSTOMS TO LIMIT GROWTH             415

12.6.2    MIDDLE EAST & AFRICA: RECESSION IMPACT   415

TABLE 513         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         416

TABLE 514         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,  2021–2029 (USD MILLION) 416

TABLE 515         MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)        417

TABLE 516         MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)        417

TABLE 517         MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,  2021–2029 (USD MILLION) 418

TABLE 518         MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      418

TABLE 519         MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT,  2021–2029 (USD MILLION) 419

TABLE 520         MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)    419

TABLE 521         MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)          419

TABLE 522         MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,  2021–2029 (USD MILLION)      420

TABLE 523         MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY PRODUCT,  2021–2029 (USD MILLION)         420

TABLE 524         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,  2021–2029 (USD MILLION)   420

TABLE 525         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)            421

TABLE 526         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,  BY TYPE, 2021–2029 (USD MILLION) 421

TABLE 527         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION,  2021–2029 (USD MILLION)   422

TABLE 528         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)            422

TABLE 529         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)            423

TABLE 530         MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,  2021–2029 (USD MILLION)         423

13          COMPETITIVE LANDSCAPE       424

13.1       OVERVIEW        424

13.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          424

13.3       REVENUE ANALYSIS      425

FIGURE 52         REVENUE ANALYSIS FOR KEY COMPANIES IN PAST FIVE YEARS              425

13.4       MARKET SHARE ANALYSIS         426

FIGURE 53         VETERINARY DIAGNOSTICS MARKET: MARKET SHARE ANALYSIS, 2022 426

13.5       COMPANY EVALUATION MATRIX          427

13.5.1    STARS  427

13.5.2    EMERGING LEADERS    427

13.5.3    PERVASIVE PLAYERS     428

13.5.4    PARTICIPANTS 428

FIGURE 54         VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022      428

13.5.5    COMPANY FOOTPRINT 429

TABLE 531         PRODUCT FOOTPRINT 429

TABLE 532         TECHNOLOGY FOOTPRINT      430

TABLE 533         END-USER FOOTPRINT 431

TABLE 534         REGION FOOTPRINT    432

TABLE 535         COMPANY FOOTPRINT 433

13.6       START-UP/SME EVALUATION MATRIX 434

13.6.1    PROGRESSIVE COMPANIES       434

13.6.2    DYNAMIC COMPANIES 434

13.6.3    STARTING BLOCKS       434

13.6.4    RESPONSIVE COMPANIES          434

FIGURE 55         VETERINARY DIAGNOSTICS MARKET: START-UP/SME EVALUATION MATRIX (2022)    435

13.6.5    COMPETITIVE BENCHMARKING            436

13.7       COMPETITIVE SCENARIO          436

13.7.1    PRODUCT LAUNCHES  437

TABLE 536         PRODUCT LAUNCHES  437

13.7.2    DEALS  437

TABLE 537         DEALS  437

13.7.3    OTHER DEVELOPMENTS           438

TABLE 538         OTHER DEVELOPMENTS           438

14          COMPANY PROFILES    439

14.1       KEY PLAYERS   439

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

14.1.1    IDEXX LABORATORIES, INC.      439

TABLE 539         IDEXX LABORATORIES, INC.: COMPANY OVERVIEW      439

FIGURE 56         IDEXX LABORATORIES: COMPANY SNAPSHOT (2022)    440

14.1.2    ZOETIS, INC.     448

TABLE 540         ZOETIS, INC.: COMPANY OVERVIEW     448

FIGURE 57         ZOETIS, INC.: COMPANY SNAPSHOT (2022)        449

14.1.3    THERMO FISHER SCIENTIFIC, INC.         455

TABLE 541         THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW     455

FIGURE 58         THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (20222)              456

14.1.4    HESKA CORPORATION (MARS INCORPORATED)            466

TABLE 542         HESKA CORPORATION: COMPANY OVERVIEW  466

FIGURE 59         HESKA CORPORATION: COMPANY SNAPSHOT (2022)    467

14.1.5    BIOMÉRIEUX SA             470

TABLE 543         BIOMÉRIEUX SA: COMPANY OVERVIEW 470

FIGURE 60         BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022)  471

14.1.6    NEOGEN CORPORATION           476

TABLE 544         NEOGEN CORPORATION: COMPANY OVERVIEW            476

FIGURE 61         NEOGEN CORPORATION: COMPANY SNAPSHOT (2022) 477

14.1.7    BIO-RAD LABORATORIES, INC. 482

TABLE 545         BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW  482

FIGURE 62         BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)              483

14.1.8    VIRBAC 486

TABLE 546         VIRBAC: COMPANY OVERVIEW 486

FIGURE 63         VIRBAC: COMPANY SNAPSHOT (2022)   486

14.1.9    FUJIFILM HOLDINGS CORPORATION    489

TABLE 547         FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW              489

FIGURE 64         FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)   490

14.1.10  SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.              491

TABLE 548         SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW      491

FIGURE 65         MINDRAY GROUP: COMPANY SNAPSHOT (2022)             491

14.1.11  INDICAL BIOSCIENCE GMBH     493

TABLE 549         INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW     493

14.1.12  BIONOTE INC.  496

TABLE 550         BIONOTE INC.: COMPANY OVERVIEW  496

14.1.13  BIOGAL GALED LABS    498

TABLE 551         BIOGAL GALED LABS: COMPANY OVERVIEW    498

14.1.14  AGROLABO S.P.A.          500

TABLE 552         AGROLABO S.P.A.: COMPANY OVERVIEW           500

14.1.15  INNOVATIVE DIAGNOSTICS      506

TABLE 553         INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW      506

14.2       OTHER PLAYERS           513

14.2.1    RANDOX LABORATORIES LTD. 513

14.2.2    BIOCHEK           514

14.2.3    FASSISI GMBH  514

14.2.4    ALVEDIA           515

14.2.5    SKYER, INC.       515

14.2.6    SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.         516

14.2.7    PRECISION BIOSENSOR 516

14.2.8    EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 517

14.2.9    GOLD STANDARD DIAGNOSTICS           517

14.2.10  ANTECH DIAGNOSTICS, INC.    518

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15          APPENDIX         519

15.1       DISCUSSION GUIDE      519

15.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             525

15.3       CUSTOMIZATION OPTIONS      527

15.4       RELATED REPORTS       527

15.5       AUTHOR DETAILS         528